BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15141121)

  • 1. Approaches to target class combinatorial library design.
    Schnur D; Beno BR; Good A; Tebben A
    Methods Mol Biol; 2004; 275():355-78. PubMed ID: 15141121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing combinatorial libraries optimized on multiple objectives.
    Gillet VJ
    Methods Mol Biol; 2004; 275():335-54. PubMed ID: 15141120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are target-family-privileged substructures truly privileged?
    Schnur DM; Hermsmeier MA; Tebben AJ
    J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2006 Jan; 49(2):490-500. PubMed ID: 16420036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score.
    Chen G; Zheng S; Luo X; Shen J; Zhu W; Liu H; Gui C; Zhang J; Zheng M; Puah CM; Chen K; Jiang H
    J Comb Chem; 2005; 7(3):398-406. PubMed ID: 15877468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and virtual screening of target libraries.
    Rognan D
    J Physiol Paris; 2006; 99(2-3):232-44. PubMed ID: 16459061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo drug design: integration of structure-based and ligand-based methods.
    Dean PM; Lloyd DG; Todorov NP
    Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical library synthesis using convergent approaches.
    Beeler AB; Schaus SE; Porco JA
    Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaffold diversity of natural products: inspiration for combinatorial library design.
    Grabowski K; Baringhaus KH; Schneider G
    Nat Prod Rep; 2008 Oct; 25(5):892-904. PubMed ID: 18820757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
    Hartenfeller M; Proschak E; Schüller A; Schneider G
    Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of combinatorial chemistry on drug discovery.
    Lee A; Breitenbucher JG
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):494-508. PubMed ID: 12951813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.